Explore our sister journals here.

Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: Journal of Medical Internet Research

Date Submitted: Sep 28, 2025
Open Peer Review Period: Sep 29, 2025 - Nov 24, 2025
Date Accepted: Jan 21, 2026
(closed for review but you can still tweet)

The final, peer-reviewed published version of this preprint can be found here:

Trends in Venture Capital Investment in AI-Driven Biopharmaceutical Startups

Bazaz AM, Ji Y, Socal M, Kang SY

Trends in Venture Capital Investment in AI-Driven Biopharmaceutical Startups

J Med Internet Res 2026;28:e84968

DOI: 10.2196/84968

PMID: 41740146

PMCID: 12980058

Trends in Venture Capital Investment in Artificial Intelligence-driven Biopharmaceutical Startups

  • Abhishek Madhav Bazaz; 
  • Yunan Ji; 
  • Mariana Socal; 
  • So-Yeon Kang

ABSTRACT

This study analyzes 2010–2024 venture capital trends in international AI-driven biopharmaceutical startups, revealing rapid growth in discovery tool investments and concentrated U.S. funding in California and Massachusetts.


 Citation

Please cite as:

Bazaz AM, Ji Y, Socal M, Kang SY

Trends in Venture Capital Investment in AI-Driven Biopharmaceutical Startups

J Med Internet Res 2026;28:e84968

DOI: 10.2196/84968

PMID: 41740146

PMCID: 12980058

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.